G04 : Engineered HBV-specific T cells: Disentangling antiviral from killing capacity

Authors

Keywords

Journal

Volume 62, Issue -, Pages S188

Publisher

Elsevier BV

Online

2015-06-11

DOI

10.1016/s0168-8278(15)30005-2

Contact the author

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now